RxDoctor Payments Data

Melissa Carlton

Nurse Practitioner · Lenoir, NCNPI 1427086743

Payments from drug & device makers

$3,924in general payments, 2019–2025

Across 282 payments — averaging $13.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$397
  • Lilly USA, LLC$365
  • AstraZeneca$315
  • Pfizer$305
  • Ironwood Pharmaceuticals, Inc$134
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$3,915100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,924 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$29,338
Medicare patients
112
Services billed
382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide267$308,723
Tresiba Flextouch U-200Insulin Degludec122$113,131
EliquisApixaban100$91,338
Trelegy ElliptaFluticasone/Umeclidin/Vilanter83$78,884
LinzessLinaclotide61$65,530
Xtampza ErOxycodone Myristate23$47,726
TrulicityDulaglutide30$42,645
MounjaroTirzepatide26$35,331
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog27$34,798
FarxigaDapagliflozin Propanediol37$34,365
MyrbetriqMirabegron30$31,685
JardianceEmpagliflozin18$30,616
VraylarCariprazine Hcl19$26,931
RybelsusSemaglutide22$25,776
Breo ElliptaFluticasone/Vilanterol47$22,590

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$397$334,499289 claims
GSKTrelegy Ellipta, Breo Ellipta$120$101,474130 claims
AbbVieLinzess, Vraylar$1,128$92,46280 claims
PfizerEliquis$305$91,338100 claims
Lilly USA, LLCTrulicity, Mounjaro$365$77,97656 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$315$56,61075 claims
Astellas Pharma US IncMyrbetriq$18$31,68530 claims
Boehringer IngelheimJardiance$88$30,61618 claims
Johnson & JohnsonXarelto$16$13,72215 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$95$10,94415 claims
BayerKerendia$90$7,69512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Lenoir

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →